The mitochondrial K ATP channel-Fact or fiction?

Journal of Molecular and Cellular Cardiology

Volumn 52, Issue 3, 2012, Pages 578-583

  Garlid, Keith D ^a   Halestrap, Andrew P ^b  

^a PORTLAND STATE UNIVERSITY   (United States)

^b UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

Heart; Ischemic preconditioning; Mitochondria; MitoK ATP; Potassium channel; Reactive oxygen species

Indexed keywords

3 HYDROXYACYL COENZYME A DEHYDROGENASE; 5 HYDROXYDECANOIC ACID; ADENOSINE TRIPHOSPHATE SENSITIVE POTASSIUM CHANNEL; BONGKREKIC ACID; CROMAKALIM; DIAZOXIDE; FLAVOPROTEIN; GLIBENCLAMIDE; MEMBRANE ENZYME; NICORANDIL; PINACIDIL; POTASSIUM CHANNEL BLOCKING AGENT; POTASSIUM ION; PROTEIN KINASE C EPSILON; REACTIVE OXYGEN METABOLITE; SUCCINATE DEHYDROGENASE (UBIQUINONE); VALINOMYCIN;

CONFORMATIONAL TRANSITION; ENZYME INHIBITION; FATTY ACID OXIDATION; HEART MITOCHONDRION; HEART MUSCLE FIBER MEMBRANE; HEART PROTECTION; HUMAN; ISCHEMIC POSTCONDITIONING; ISCHEMIC PRECONDITIONING; LIGHT SCATTERING; MITOCHONDRIAL PERMEABILITY; NONHUMAN; NOTE; POTASSIUM TRANSPORT; PRIORITY JOURNAL;

ANIMALS; HUMANS; ISCHEMIC PRECONDITIONING, MYOCARDIAL; MITOCHONDRIA, HEART; POTASSIUM CHANNEL BLOCKERS; POTASSIUM CHANNELS;

EID: 84857627495     PISSN: 00222828     EISSN: 10958584     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2011.12.011     Document Type: Note

References (57)

1. Halestrap A.P. The regulation of the matrix volume of mammalian mitochondria in vivo and in vitro and its role in the control of mitochondrial metabolism. Biochim Biophys Acta 1989, 973:355-382.
2. + cycle. Biochim Biophys Acta 2003, 1606:23-41.
3. Garlid K.D., Beavis A.D., Ratkje S.K. On the nature of ion leaks in energy-transducing membranes. Biochim Biophys Acta 1989, 976:109-120.
4. Murphy E., Steenbergen C. Mechanisms underlying acute protection from cardiac ischemia-reperfusion injury. Physiol Rev 2008, 88:581-609.
5. Yang X., Cohen M.V., Downey J.M. Mechanism of cardioprotection by early ischemic preconditioning. Cardiovasc Drugs Ther 2010, 24:225-234.
6. + channel in cardiac function and cardioprotection. Biochim Biophys Acta 2003, 1606:1-21.
7. ATP channel as a receptor for potassium channel openers. J Biol Chem 1996, 271:8796-8799.
8. + channels. Possible mechanism of cardioprotection. Circ Res 1997, 81:1072-1082.
9. ATP co-purify and co-reconstitute to form a functioning signaling module in proteoliposomes. Circ Res 2006, 99:878-883.
10. Garlid K.D., Costa A.D.T., Quinlan C.L., Pierre S.V., Dos Santos P. Cardioprotective signaling to mitochondria. J Mol Cell Cardiol 2009, 46:858-866.
11. Beavis A.D., Brannan R.D., Garlid K.D. Swelling and contraction of the mitochondrial matrix. I. A structural interpretation of the relationship between light scattering and matrix volume. J Biol Chem 1985, 260:13424-13433.
12. Garlid K.D., Beavis A.D. Swelling and contraction of the mitochondrial matrix. II. Quantitative application of the light scattering technique to solute transport across the inner membrane. J Biol Chem 1985, 260:13434-13441.
13. ATP channels in rat mitochondria. J Physiol 2003, 547:893-902.
14. ATP opening on heart mitochondria. Am J Physiol 2006, 290:H406-H415.
15. Wojtovich A.P., Williams D.M., Karcz M.K., Lopes C.M., Gray D.A., Nehrke K.W., et al. A novel mitochondrial K(ATP) channel assay. Circ Res 2010, 106:1190-1196.
16. Eliseev R.A., Vanwinkle B., Rosier R.N., Gunter T.E. Diazoxide-mediated preconditioning against apoptosis involves activation of cAMP-response element-binding protein (CREB) and NFkappaB. J Biol Chem 2004, 279:46748-46754.
17. Rousou A.J., Ericsson M., Federman M., Levitsky S., McCully J.D. Opening of mitochondrial KATP channels enhances cardioprotection through the modulation of mitochondrial matrix volume, calcium accumulation, and respiration. Am J Physiol 2004, 287:H1967-H1976.
18. Juhaszova M., Zorov D.B., Kim S.H., Pepe S., Fu Q., Fishbein K.W., et al. Glycogen synthase kinase-3beta mediates convergence of protection signaling to inhibit the mitochondrial permeability transition pore. J Clin Invest 2004, 113:1535-1549.
19. Wojtovich A.P., Brookes P.S. The endogenous mitochondrial complex II inhibitor malonate regulates mitochondrial ATP-sensitive potassium channels: implications for ischemic preconditioning. Biochim Biophys Acta 2008, 1777:882-889.
20. Auchampach J.A., Grover G.J., Gross G.J. Blockade of ischaemic preconditioning in dogs by the novel ATP dependent potassium channel antagonist sodium 5-hydroxydecanoate. Cardiovasc Res 1992, 26:1054-1062.
21. + channel of heart mitochondria. Am J Physiol 2001, 280:H649-H657.
22. Grimmsmann T., Rustenbeck I. Direct effects of diazoxide on mitochondria in pancreatic B-cells and on isolated liver mitochondria. Br J Pharmacol 1998, 123:781-788.
23. ATP channel-independent targets of diazoxide and 5-hydroxydecanoate in the heart. J Physiol 2002, 542:735-741.
24. Lim K.H., Javadov S.A., Das M., Clarke S.J., Suleiman M.S., Halestrap A.P. The effects of ischaemic preconditioning, diazoxide and 5-hydroxydecanoate on rat heart mitochondrial volume and respiration. J Physiol 2002, 545:961-974.
25. Hanley P.J., Daut J. K(ATP) channels and preconditioning: a re-examination of the role of mitochondrial K(ATP) channels and an overview of alternative mechanisms. J Mol Cell Cardiol 2005, 39:17-50.
26. Drose S., Brandt U., Hanley P.J. K+-independent actions of diazoxide question the role of inner membrane KATP channels in mitochondrial cytoprotective signaling. J Biol Chem 2006, 281:23733-23739.
27. Minners J., Lacerda L., Yellon D., Opie L., McLeod C., Sack M. Diazoxide-induced respiratory inhibition - a putative mitochondrial KATP channel independent mechanism of pharmacological preconditioning. Mol Cell Biochem 2007, 294:11-18.
28. Drose S., Hanley P.J., Brandt U. Ambivalent effects of diazoxide on mitochondrial ROS production at respiratory chain complexes I and III. Biochim Biophys Acta 2009, 1790:558-565.
29. ATP channel. Am J Physiol 2001, 280:H2406-H2411.
30. Ardehali H., Chen Z., Ko Y., Mejia-Alvarez R., Marban E. Multiprotein complex containing succinate dehydrogenase confers mitochondrial ATP-sensitive K+ channel activity. Proc Natl Acad Sci U S A 2004, 101:11880-11885.
31. Wojtovich A.P., Brookes P.S. The complex II inhibitor atpenin A5 protects against cardiac ischemia-reperfusion injury via activation of mitochondrial KATP channels. Basic Res Cardiol 2009, 104:121-129.
32. Wojtovich A.P., Nehrke K.W., Brookes P.S. The mitochondrial complex II and ATP-sensitive potassium channel interaction: quantitation of the channel in heart mitochondria. Acta Biochim Pol 2010, 57:431-434.
33. Bednarczyk P., Barker G.D., Halestrap A.P. Determination of the rate of K(+) movement through potassium channels in isolated rat heart and liver mitochondria. Biochim Biophys Acta 2008, 1777:540-548.
34. + channel for cardiac protection against ischemic injury is dependent on protein kinase C activity. Circ Res 1999, 85:731-741.
35. ATP channels with molecularly defined surface K(ATP) channels. Mol Pharmacol 2001, 59:225-230.
36. Pasdois P., Beauvoit B., Tariosse L., Vinassa B., Bonoron-Adele S., Dos Santos P. Effect of diazoxide on flavoprotein oxidation and reactive oxygen species generation during ischemia-reperfusion: a study on Langendorff-perfused rat hearts using optic fibers. Am J Physiol 2008, 294:H2088-H2097.
37. Clarke S.J., Khaliulin I., Das M., Parker J.E., Heesom K.J., Halestrap A.P. Inhibition of mitochondrial permeability transition pore opening by ischemic preconditioning is probably mediated by reduction of oxidative stress rather than mitochondrial protein phosphorylation. Circ Res 2008, 102:1082-1090.
38. Klingenberg M., Grebe K., Scherer B. Opposite effects of bongkrekic acid and atractyloside on the adenine nucleotides induced mitochondrial volume changes and on the efflux of adenine nucleotides. FEBS Lett 1971, 16:253-256.
39. Stoner C.D., Sirak H.D. Adenine nucleotide-induced contraction on the inner mitochondrial membrane. II. Effect of bongkrekic acid. J Cell Biol 1973, 56:65-73.
40. Halestrap A.P., Davidson A.M. Inhibition of Ca2(+)-induced large-amplitude swelling of liver and heart mitochondria by cyclosporin is probably caused by the inhibitor binding to mitochondrial-matrix peptidyl-prolyl cis-trans isomerase and preventing it interacting with the adenine nucleotide translocase. Biochem J 1990, 268:153-160.
41. Brustovetsky T., Shalbuyeva N., Brustovetsky N. Lack of manifestations of diazoxide/5-hydroxydecanoate-sensitive KATP channel in rat brain non-synaptosomal mitochondria. J Physiol 2005, 568:47-59.
42. Szewczyk A., Skalska J., Glab M., Kulawiak B., Malinska D., Koszela-Piotrowska I., et al. Mitochondrial potassium channels: from pharmacology to function. Biochim Biophys Acta 2006, 1757:715-720.
43. Halestrap A.P., Clarke S.J., Khaliulin I. The role of mitochondria in protection of the heart by preconditioning. Biochim Biophys Acta 2007, 1767:1007-1031.
44. D'Hahan N., Moreau C., Prost A.L., Jacquet H., Alekseev A.E., Terzic A., et al. Pharmacological plasticity of cardiac ATP-sensitive potassium channels toward diazoxide revealed by ADP. Proc Natl Acad Sci U S A 1999, 96:12162-12167.
45. Suzuki M., Saito T., Sato T., Tamagawa M., Miki T., Seino S., et al. Cardioprotective effect of diazoxide is mediated by activation of sarcolemmal but not mitochondrial ATP-sensitive potassium channels in mice. Circulation 2003, 107:682-685.
46. Notsu T., Tanaka I., Takano M., Noma A. Blockade of the ATP-sensitive K+ channel by 5-hydroxydecanoate in guinea pig ventricular myocytes. J Pharmacol Exp Ther 1992, 260:702-708.
47. Kane G.C., Liu X.K., Yamada S., Olson T.M., Terzic A. Cardiac KATP channels in health and disease. J Mol Cell Cardiol 2005, 38:937-943.
48. ATP channels in cardioprotection against ischemia/reperfusion injury in mice. J Clin Invest 2002, 109:509-516.
49. Gumina R.J., Pucar D., Bast P., Hodgson D.M., Kurtz C.E., Dzeja P.P., et al. Knockout of Kir6.2 negates ischemic preconditioning-induced protection of myocardial energetics. Am J Physiol Heart Circ Physiol 2003, 284:H2106-H2113.
50. Gumina R.J., O'Cochlain D.F., Kurtz C.E., Bast P., Pucar D., Mishra P., et al. KATP channel knockout worsens myocardial calcium stress load in vivo and impairs recovery in stunned heart. Am J Physiol Heart Circ Physiol 2007, 292:H1706-H1713.
51. Camara A.K., Bienengraeber M., Stowe D.F. Mitochondrial approaches to protect against cardiac ischemia and reperfusion injury. Front Physiol 2011, 2:2-13.
52. Camara A.K., Lesnefsky E.J., Stowe D.F. Potential therapeutic benefits of strategies directed to mitochondria. Antioxid Redox Signal 2010, 13:279-347.
53. ATP increases superoxide generation from Complex I of the electron transport chain. Am J Physiol 2006, 291:H2067-H2074.
54. ATP blocker sodium 5-hydroxydecanoate does not abolish preconditioning in isolated rat hearts. Eur J Pharmacol 1995, 277:271-274.
55. Hanley P.J., Drose S., Brandt U., Lareau R.A., Banerjee A.L., Srivastava D.K., et al. 5-Hydroxydecanoate is metabolised in mitochondria and creates a rate-limiting bottleneck for beta-oxidation of fatty acids. J Physiol 2005, 562:307-318.
56. Garlid K.D. The state of water in biological systems. Int Rev Cytol 2000, 192:281-302.
57. Baines C.P., Song C.X., Zheng Y.T., Wang G.W., Zhang J., Wang O.L., et al. Protein kinase Cepsilon interacts with and inhibits the permeability transition pore in cardiac mitochondria. Circ Res 2003, 92:873-880.